Claims for Patent: 11,083,781
✉ Email this page to a colleague
Summary for Patent: 11,083,781
Title: | Collagenase Clostridium Histolyticum injection therapies |
Abstract: | Collagenase (EN3835) is a proteinase that can hydrolyze the triple-helical region of collagen under physiological conditions. EN3835 targets the collagenase structural matrix at the site of injection and does not require systemic exposure. Embodiments include methods of lysing subdermal collagen to treat various conditions such as benign prostatic hyperplasia, tracheal stenosis, subglottic stenosis and scleroderma. |
Inventor(s): | Joseph John |
Assignee: | InnoMed Technologies, Inc. |
Application Number: | US17066463 |
Patent Claims: |
Details for Patent 11,083,781
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | June 04, 1965 | 11,083,781 | 2040-10-08 |
Auxilium Pharmaceuticals, Inc. | XIAFLEX | collagenase clostridium histolyticum | For Injection | 125338 | February 02, 2010 | 11,083,781 | 2040-10-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |